Marianne Brodmann

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.

Dr Konstantinos Katsanos finished his graduate studies in the School of Medicine, University of Patras, Greece in 2001, and continued his post-graduate studies and received an MSc degree in Pharmacology and Pharmacokinetics in 2006 and then a PhD thesis in 2009 in the field of therapeutic angiogenesis and arteriogenesis. He completed a subspecialty fellowship in Interventional Radiology in Guy's and St.Thomas' Hospitals, London, UK in 2008 and was among the first who sat for and received the European Boards in Interventional Radiology (EBIR) in late 2010 by the Cardiovascular and Interventional radiological Society of Europe (CIRSE). His current academic interests are focused on endovascular therapies of lower limb ischemia and failing dialysis access, as well as on interventional spine and vascular oncologic embolization procedures. He has already demonstrated a record of successful and productive basic and applied research. He has authored or co-authored more than 250 original papers in international peer-reviewed journals. In addition, he has presented numerous oral free papers and scientific presentations and has delivered numerous invited lectures in international conferences and symposia. He has been included in World’s Top 2% Scientists’ List by Stanford University.

Dr Kum received his medical degree from the National University of Singapore in 2000 and
subsequently embarked on his surgical training with the Royal College of Surgeons,
obtaining his Master of Medicine and Fellowship in 2007.
In 2009, he completed his Postgraduate Fellowship in Vascular and Endovascular Surgery at
the Prince of Wales Hospital, Sydney as well as at the Department of Angiology, Heart
Centre Leipzig. In 2012, he completed a second Fellowship on Advanced Techniques in
Diabetic Limb Salvage and Wound Care Techniques in Milan.
Since 2015, Dr Kum has been the Director of Vascular Surgery at Department of Surgery,
Changi General Hospital Singapore and he was subsequently appointed as a Visiting
Consultant in 2019. He currently maintains his practice at Mount Elizabeth Novena
Hospital, Singapore and is currently the CMO of M & L Healthcare. Dr Kum is the past President of the
Society for Vascular and Endovascular Surgeons of Singapore (SVESS) and is part of the organizing committee of
Critical Issues in Endovascular Therapy, a regional meeting organized by the society.
Dr Kum has a keen interest in clinical research revolving around Diabetic Limb Salvage. He is
one of the pioneers in Percutaneous Deep Arterialization for no-option Critical Limb
Ischemia for which he has authored or co-authored numerous papers. He is the PI or co-PI
for several industry or physician led studies. He is also a keen innovator who is currently
working on several disruptive technologies.

Interventional angiologist, Head of Vascular Centre Berlin Alexianer St. Gertrauden-Hospital, Board Member of the German Society of Angiology, personal case load >20.000 cases, academic research primarily endovascular therapy

Dr Lobato has been a Vascular and endovascular Surgery Consultant in Hospital Universitario de Cruces (Bilbao-Spain) since 2010. Her Department is considered a first line Unit in the Endovascular management of CLTI ( particularly in the BTK-BTA segments). She developed her Vascular Fellowship Programme in Hospital Universitario Doce de Octubre (Madrid) and thereafter completed her training with short stages in Hospital du Nord St Etienne (France), Universitäs Spital Zurich. (Switzerland), St Franziskus Hospital Münster.(Germany)
For the last ten years her activity has been mainly focused in the endovascular treatment of the lower limb,routinely performing complex CTO revascularizations, including any sort of bidirectional access, transcollateral approaches, plantar loop or venous arterialization. She is also a reviewer of the Critical Limb ischaemia Journal, Journal of Endovascular Therapy, Annals of Vascular Surgery, Journal of Cardiovascular Surgery and VASA European Jornal of Vascular Medicine. Her Unit has presented multiple communications in well recognized international symposiums and has published many papers in first line journals of her speciality

Jos C. van den Berg graduated from the Medical School of the State University of Leiden (NL) in 1986. The army was served in 1986-1988 as radiological resident at the Military Hospital "Dr. A. Mathijssen" in Utrecht (NL). In 1988 he started his radiology training program in the St. Radboud University Hospital, Nijmegen (NL). In 1994 he started working as an interventional radiologist at the Department of Radiology in the St. Antonius Hospital, Nieuwegein (NL) and since July 2001 he was Head of the Department of Radiology of this institution.
In July 2004 he started working as head of the Service of Interventional Radiology in the Ospedale Regionale di Lugano, Switzerland. He currently works in the Clinica Luganese Moncucco, Lugano, Switzerland and is associate professor of radiology (Privat Dozent) at the Medical Faculty of the University of Bern.
He has (co-)authored over 270 publications in peer-reviewed scientific journals and books.
He is Editor in Chief of the Journal of Critical Limb Ischemia reviewer, former Associate Editor of JVIR and member of the Editorial Board for European Radiology, EJVES, the Journal of Endovascular Therapy, CVIR Endovascular and JCVS and reviewer for JVIR, VASCULAR, JVS, EJR, Annals of Vascular Surgery, JIC, Acta Radiologica, JACC Cardiovascular Interventions, PlosOne, and CVIR. He is Board Member of the CLI Global Society and Chairman of the European Office of the CLI Global Society. He is Course Director of the AMP meeting in Chicago and AMP Europe, and Course Co-Director of the EVC meeting in Maastricht.

Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospital where he is director of surgery, anaesthetics and perioperative services for the South Eastern Sydney Local Health District. He is also director of the Prince of Wales operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for which he is internationally renowned.

He has a strong academic interest in novel stent and anastomotic technologies, the investigation of intimal hyperplasia, and cellular mechanisms, and has the first-in-man experience with the Absorb bioresorbable stent technology applied below-the-knee. In 2015, he completed his PhD and in 2020 he completed a Masters in Clinical Epidemiology focussing on clinical trial design and biostatistics at the University of Sydney.

He is a Professor at the University of New South Wales where he teaches regularly. He is founder and course director of the New South Wales Vascular meeting and the VERVE symposium, the largest annual endovascular summit in Australasia.

He is a member of numerous learned societies, has published more than 130 peer reviewed manuscripts, five book chapters, is an invited reviewer for multiple leading journal in the field of vascular medicine, intervention and science, is on the editorial board of several of those same journals. He has been invited to speak both nationally and internationally on more than 300 individual occasions.

Dr Ysa has been a Vascular and Endovascular Surgery Consultant in Hospital de Cruces (Barakaldo. Spain) since 2003. His Department is a well known institution in the endovascular management of CLTI patients. He developed his Vascular Fellowship Programme in Hospital del Mar (Barcelona. Spain) and thereafter completed his training with short stages in Montefiore Hospital (F. Veith. NY. USA) and Houston Methodist Hospital (TX. USA). In 2006 he became Fellow of the European Board of Vascular Surgery and in 2011 he joined St Mary´s Hospital (London. UK) as a Senior Specialist Registrar.
For the last ten years his activity has been mainly focussed in the endovascular treatment of the lower limbs, being the co-director of the complex BTK/BTA revascularization Unit of his Department. He is also a reviewer of the Annals of Vascular Surgery and Journal of Endovascular Therapy since 2008 and 2019.
His Unit has presented multiple communications in well-recognized international symposiums and has published many papers in first-line journals of his specialty. In 2020, his clip “ Proximal venous arterialization using conventional “off-the-shelf” devices” was awarded as the most innovative video of the European Society in Vascular Surgery Masterclass.

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.

Dr. Mathews is an interventional cardiologist and endovascular specialist at Bradenton Cardiology Center in Bradenton, FL specializing in complex coronary interventions, structural heart procedures, endovascular therapies, and novel device research. He did his undergraduate training at Rensselaer Polytechnic Institute in Troy, NY receiving a degree in Biology and Electronic Media Arts & Communication and subsequently working in the multimedia technology sector. He later went on to graduate and professional training at Tufts University in Boston, MA where he received his MD and Master's in Health Communication at the Sackler School of Biomedical Sciences focusing on telemedicine and interactive education. He completed residency training and fellowship training in Cardiovascular Disease, Advanced Cardiac Imaging, and Interventional Cardiology at the Washington University School of Medicine in St. Louis, MO. He is currently global and national principal investigator in several trials and is actively involved in endovascular research.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Dr. Wiechmann has been in private practice for 28 years with Vascular & Interventional Physicians in Gainesville, Florida, USA, with a particular interest in peripheral arterial disease & critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow in 4 different medical associations, including the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS) and has served in many leadership roles in these societies. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is past-President of OEIS. He has given over 270 invited lectures, has been principal investigator in numerous clinical trials in peripheral arterial intervention, carotid stenting, medical therapy for PAD, and stem cell therapy for critical limb ischemia, and is lead or co-author on over 35 peer-reviewed articles.

John H. Rundback, MD, FAHA, FSVMB, FSIR

John H. Rundback, MD, is an Interventional Radiologist in practice since 1993, and is the Managing Partner of Advanced Interventional & Vascular Services LLP as well as a partner in Premier Endovascular in NJ. Dr. Rundback is board-certified in radiology and holds a Certificate of Added Qualification in Angiography and Interventional Radiology. He has been recognized as a Top Doctor by Castle Connolly.

Dr. Rundback's clinical and research interests focus on peripheral arterial disease, particularly complex tibiopedal therapies and deep venous arterialization for limb salvage, as well as venous interventions, carotid stenting, endovascular aneurysm repair. He has served as the principal investigator in many multi-center trials, presented at over 300 conferences, and published more than 100 peer-reviewed articles. Additionally, Dr. Rundback sits on the Scientific Advisory Board for multiple Strategic Device Companies, is CMO of a the ORCA Clinical Trials Network, and serves as an advisor and editorial board member for several medical journals.

Dr. Rundback is a past member of the Board of Directors of the Society of Interventional Radiology Foundation the Board of VIVA Physicians. Currently, he is an active board member of the CLI Global Society.

Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist at Beth Israel Deaconess Medical Center. He is also Section Head of Interventional Cardiology and Vascular Research at the Smith Center for Outcomes Research in Cardiology and an Associate Professor of Medicine at Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab, and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease.

Dr. Secemsky leads the vascular and interventional research program at the Smith Center. His research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on peripheral vascular disorders. Dr. Secemsky is involved in clinical trial design and implementation, and has served as an investigator on more than a dozen trials. Dr. Secemsky’s research program is funded by the National Institutes of Health, Harvard Medical School, extramural grants and philanthropy. Dr. Secemsky has authored more than 300 publications. He is an Associate Editor at Vascular Medicine and is on the Editorial Board at Circulation: Cardiovascular Interventions and Journal of SCAI. He is on the Board of Directors for the VIVA Foundation, PERT Consortium and the Society for Vascular Medicine, and is the co-chair of the Vascular Disease Council for SCAI.